GRAHAM PETER J 4

4 · ANTARES PHARMA, INC. · Filed Jun 14, 2021

Form 4

Period: 2021-06-10

SVP General Counsel, Secretary

Transactions

Award
Common Stock
2021-06-10$4.42/sh+85,973$380,001→ 632,231 total
Award
Stock Option (right to buy)
2021-06-10+163,963→ 163,963 total
Exercise: $4.42Exp: 2031-06-10→ Common Stock (163,963 underlying)
Tax Payment
Common Stock
2021-06-13$4.45/sh−14,790$65,816→ 594,431 total
Tax Payment
Common Stock
2021-06-11$4.45/sh−23,010$102,395→ 609,221 total

Footnotes (4)

[F1]Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant.
[F2]Represents the payment of tax liability using a portion of securities received from the company in connection with the vesting of a previously granted restricted stock unit award. The shares of common stock reported herein were withheld by the company to cover tax liability and not actually sold.
[F3]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan.
[F4]The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date.

Documents

1 file